References

1. Cohen, A.J.; Brauer, M.; Burnett, R.; Anderson, H.R.; Frostad, J.; Estep, K.; Balakrishnan, K.; Brunekreef, B.; Dandona, L.; Dandona, R.; et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: An analysis of data from the Global Burden of Diseases Study 2015. Lancet 2017, 389, 1907–1918.
2. Di, Q.; Wang, Y.; Zanobetti, A.; Wang, Y.; Koutrakis, P.; Choirat, C.; Dominici, F.; Schwartz, J.D. Air Pollution and Mortality in the Medicare Population. N. Engl. J. Med. 2017, 376, 2513–2522.
3. Abellán, R.; Mansego, M.L.; Martínez-Hervás, S.; Martín-Escudero, J.C.; Carmena, R.; Real, J.T.; Redon, J.; Castrodeza-Sanz, J.J.; Chaves, F.J. Association of selected ABC gene family single nucleotide polymorphisms with postprandial lipoproteins: Results from the population-based Hortega study. Atherosclerosis 2010, 211, 203–209.
4. Kemp, A.C.; Horton, B.P.; Donnelly, J.P.; Mann, M.E.; Vermeer, M.; Rahmstorf, S. Climate related sea-level variations over the past two millennia. Proc. Natl. Acad. Sci. USA 2011, 108, 11017–11022.
5. Swenberg, J.A.; Moeller, B.C.; Lu, K.; Rager, J.E.; Fry, R.C.; Starr, T.B. Formaldehyde carcinogenicity research: 30 years and counting for mode of action, epidemiology, and cancer risk assessment. Toxicol. Pathol. 2013, 41, 181–189.
6. Zhang, J.; Smith, K.R. Indoor air pollution: A global health concern. Br. Med. Bull. 2003, 68, 209–225.
7. Eftim, S.E.; Samet, J.M.; Janes, H.; McDermott, A.; Dominici, F. Fine particulate matter and mortality: A comparison of the six cities and American Cancer Society cohorts with a medicare cohort. Epidemiology 2008, 19, 209–216.
8. Pope, C.A., 3rd. Air pollution and health-good news and bad. N. Engl. J. Med. 2004, 351, 1132–1134.
9. Pope, C.A., 3rd; Dockery, D.W. Health effects of fine particulate air pollution: Lines that connect. J. Air. Waste Manag. Assoc. 2006, 56, 709–742.
10. Saxena, R.; Srivastava, S.; Trivedi, D.; Anand, E.; Joshi, S.; Gupta, S.K. Impact of environmental pollution on the eye. Acta Ophthalmol. Scand. 2003, 81, 491–494.
11. Tuominen, I.S.; Konttinen, Y.T.; Vesaluoma, M.H.; Moilanen, J.A.; Helintö, M.; Tervo, T.M. Corneal innervation and morphology in primary Sjögren’s syndrome. Invest. Ophthalmol. Vis. Sci. 2003, 44, 2545–2549.
12. Al-Aqaba, M.A.; Dhillon, V.K.; Mohammed, I.; Said, D.G.; Dua, H.S. Corneal nerves in health and disease. Prog. Retin. Eye Res. 2019, 73, 100762.
13. Koh, S.; Tung, C.I.; Inoue, Y.; Jhanji, V. Effects of tear film dynamics on quality of vision. Br. J. Ophthalmol. 2018, 102, 1615–1620.
14. Schwela, D. Air pollution and health in urban areas. Rev. Environ. Health 2000, 15, 13–42.
15. Versura, P.; Profazio, V.; Cellini, M.; Torreggiani, A.; Caramazza, R. Eye discomfort and air pollution. Ophthalmologica 1999, 213, 103–109.
16. Mimura, T.; Ichinose, T.; Yamagami, S.; Fujishima, H.; Kamei, Y.; Goto, M.; Takada, S.; Matsubara, M. Airborne particulate matter (PM2.5) and the prevalence of allergic conjunctivitis in Japan. Sci. Total Environ. 2014, 487, 493–499.
17. Hong, J.; Zhong, T.; Li, H.; Xu, J.; Ye, X.; Mu, Z.; Lu, Y.; Mashaghi, A.; Zhou, Y.; Tan, M.; et al. Ambient air pollution, weather changes, and outpatient visits for allergic conjunctivitis: A retrospective registry study. Sci. Rep. 2016, 6, 23858.
18. Wang, W.; He, M.; Li, Z.; Huang, W. Epidemiological variations and trends in health burden of glaucoma worldwide. Acta Ophthalmol. 2019, 97, e349–e355.
19. Chua, S.Y.L.; Khawaja, A.P.; Morgan, J.; Strouthidis, N.; Reisman, C.; Dick, A.D.; Khaw, P.T.; Patel, P.J.; Foster, P.J. The Relationship Between Ambient Atmospheric Fine Particulate Matter (PM2.5) and Glaucoma in a Large Community Cohort. Invest Ophthalmol. Vis. Sci. 2019, 60, 4915–4923.
20. Raju, P.; George, R.; Ve Ramesh, S.; Arvind, H.; Baskaran, M.; Vijaya, L. Influence of tobacco use on cataract development. Br. J. Ophthalmol. 2006, 90, 1374–1377.
21. Chang, K.-H.; Hsu, P.-Y.; Lin, C.-J.; Lin, C.-L.; Juo, S.-H.H.; Liang, C.-L. Traffic-related air pollutants increase the risk for age-related macular degeneration. J. Investig. Med. 2019, 67, 1076.
22. Brook, R.D.; Rajagopalan, S.; Pope, C.A., 3rd; Brook, J.R.; Bhatnagar, A.; Diez-Roux, A.V.; Holguin, F.; Hong, Y.; Luepker, R.V.; Mittleman, M.A.; et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation 2010, 121, 2331–2378.
23. Jarrett, S.G.; Boulton, M.E. Consequences of oxidative stress in age-related macular degeneration. Mol. Asp. Med. 2012, 33, 399–417.
24. Lee, H.; Hwang-Bo, H.; Ji, S.Y.; Kim, M.Y.; Kim, S.Y.; Park, C.; Hong, S.H.; Kim, G.Y.; Song, K.S.; Hyun, J.W.; et al. Diesel particulate matter2.5 promotes epithelial-mesenchymal transition of human retinal pigment epithelial cells via generation of reactive oxygen species. Environ. Pollut. 2020, 262, 114301.
25. Wei, C.C.; Lin, H.J.; Lim, Y.P.; Chen, C.S.; Chang, C.Y.; Lin, C.J.; Chen, J.J.; Tien, P.T.; Lin, C.L.; Wan, L. PM2.5 and NOx exposure promote myopia: Clinical evidence and experimental proof. Environ. Pollut. 2019, 254, 113031.
26. Chua, S.Y.L.; Khawaja, A.P.; Dick, A.D.; Morgan, J.; Dhillon, B.; Lotery, A.J.; Strouthidis, N.G.; Reisman, C.; Peto, T.; Khaw, P.T.; et al. Ambient Air Pollution Associations with Retinal Morphology in the UK Biobank. Investig. Ophthalmol. Vis. Sci. 2020, 61, 32.
27. Pan, S.C.; Huang, C.C.; Chin, W.S.; Chen, B.Y.; Chan, C.C.; Guo, Y.L. Association between air pollution exposure and diabetic retinopathy among diabetics. Environ. Res. 2020, 181, 108960.
28. Shan, A.; Chen, X.; Yang, X.; Yao, B.; Liang, F.; Yang, Z.; Liu, F.; Chen, S.; Yan, X.; Huang, J.; et al. Association between long-term exposure to fine particulate matter and diabetic retinopathy among diabetic patients: A national cross-sectional study in China. Environ. Int. 2021, 154, 106568.
29. West, S.K.; Bates, M.N.; Lee, J.S.; Schaumberg, D.A.; Lee, D.J.; Adair-Rohani, H.; Chen, D.F.; Araj, H. Is household air pollution a risk factor for eye disease? Int. J. Environ. Res. Public Health 2013, 10, 5378–5398.
30. Kabir, E.; Kim, K.H. An investigation on hazardous and odorous pollutant emission during cooking activities. J. Hazard. Mater. 2011, 188, 443–454.
31. Aitio, A.; Axelson, O.; Blair, A.; Bond, J.A.; Bucher, J.R.; Caldwell, J.; Coggon, D.; Demers, P.A.; Dragani, T.A.; Elcombe, C.R.; et al. Outdoor Air Pollution. IARC Monogr. Eval. Carcinog. Risks Hum. 2016, 109, 9–444.
32. Huff, R.D.; Carlsten, C.; Hirota, J.A. An update on immunologic mechanisms in the respiratory mucosa in response to air pollutants. J. Allergy Clin. Immunol. 2019, 143, 1989–2001.
33. Wolkoff, P. External eye symptoms in indoor environments. Indoor Air 2017, 27, 246–260.
34. Wolkoff, P. Indoor air pollutants in office environments: Assessment of comfort, health, and performance. Int. J. Hyg. Environ. Health 2013, 216, 371–394.
35. Jaén, C.; Dalton, P. Asthma and odors: The role of risk perception in asthma exacerbation. J. Psychosom. Res. 2014, 77, 302–308.
36. Luengas, A.; Barona, A.; Hort, C.; Gallastegui, G.; Platel, V.; Elias, A. A review of indoor air treatment technologies. Rev. Environ. Sci. Bio/Technol. 2015, 14, 499–522.
37. de Juniac, A.; Kreis, I.; Ibison, J.; Murray, V. Epidemiology of unintentional carbon monoxide fatalities in the UK. Int. J. Environ. Health Res. 2012, 22, 210–219.
38. Sarigiannis, D.A.; Karakitsios, S.P.; Gotti, A.; Liakos, I.L.; Katsoyiannis, A. Exposure to major volatile organic compounds and carbonyls in European indoor environments and associated health risk. Environ. Int. 2011, 37, 743–765.
39. Jordan, R.E.; Cheng, K.K.; Miller, M.R.; Adab, P. Passive smoking and chronic obstructive pulmonary disease: Cross-sectional analysis of data from the Health Survey for England. BMJ Open 2011, 1, e000153.
40. Blanc, P.D.; Eisner, M.D.; Katz, P.P.; Yen, I.H.; Archea, C.; Earnest, G.; Janson, S.; Masharani, U.B.; Quinlan, P.J.; Hammond, S.K.; et al. Impact of the home indoor environment on adult asthma and rhinitis. J. Occup. Environ. Med. 2005, 47, 362–372.
41. Rushton, L. Health impact of environmental tobacco smoke in the home. Rev. Environ. Health 2004, 19, 291–309.
42. Hetland, R.B.; Cassee, F.R.; Låg, M.; Refsnes, M.; Dybing, E.; Schwarze, P.E. Cytokine release from alveolar macrophages exposed to ambient particulate matter: Heterogeneity in relation to size, city and season. Part. Fibre Toxicol. 2005, 2, 4.
43. Vohra, K.; Vodonos, A.; Schwartz, J.; Marais, E.A.; Sulprizio, M.P.; Mickley, L.J. Global mortality from outdoor fine particle pollution generated by fossil fuel combustion: Results from GEOS-Chem. Environ. Res. 2021, 195, 110754.
44. Gawande, S.; Tiwari, R.R.; Narayanan, P.; Bhadri, A. Indoor Air Quality and Sick Building Syndrome: Are Green Buildings Better than Conventional Buildings? Indian J. Occup. Environ. Med. 2020, 24, 30–32.
45. Martheswaran, T.; Shmunes, M.H.; Ronquillo, Y.C.; Moshirfar, M. The impact of vaping on ocular health: A literature review. Int. Ophthalmol. 2021, 41, 2925–2932.
46. Choi, W.; Lian, C.; Ying, L.; Kim, G.E.; You, I.C.; Park, S.H.; Yoon, K.C. Expression of Lipid Peroxidation Markers in the Tear Film and Ocular Surface of Patients with Non-Sjogren Syndrome: Potential Biomarkers for Dry Eye Disease. Curr. Eye Res. 2016, 41, 1143–1149.
47. Yang, Q.; Li, K.; Li, D.; Zhang, Y.; Liu, X.; Wu, K. Effects of fine particulate matter on the ocular surface: An in vitro and in vivo study. Biomed. Pharmacother. 2019, 117, 109177.
48. Bascom, R.; Kulle, T.; Kagey-Sobotka, A.; Proud, D. Upper respiratory tract environmental tobacco smoke sensitivity. Am. Rev. Respir. Dis. 1991, 143, 1304–1311.
49. Kappos, A.D.; Bruckmann, P.; Eikmann, T.; Englert, N.; Heinrich, U.; Höppe, P.; Koch, E.; Krause, G.H.; Kreyling, W.G.; Rauchfuss, K.; et al. Health effects of particles in ambient air. Int. J. Hyg. Environ. Health 2004, 207, 399–407.
50. Holguin, F. Traffic, outdoor air pollution, and asthma. Immunol. Allergy Clin. N. Am. 2008, 28, 577–588.
51. McCreanor, J.; Cullinan, P.; Nieuwenhuijsen, M.J.; Stewart-Evans, J.; Malliarou, E.; Jarup, L.; Harrington, R.; Svartengren, M.; Han, I.K.; Ohman-Strickland, P.; et al. Respiratory effects of exposure to diesel traffic in persons with asthma. N. Engl. J. Med. 2007, 357, 2348–2358.
52. Annesi-Maesano, I.; Oryszczyn, M.P.; Raherison, C.; Kopferschmitt, C.; Pauli, G.; Taytard, A.; Tunon de Lara, M.; Vervloet, D.; Charpin, D. Increased prevalence of asthma and allied diseases among active adolescent tobacco smokers after controlling for passive smoking exposure. A cause for concern? Clin. Exp. Allergy 2004, 34, 1017–1023.
53. Díaz, E.; Smith-Sivertsen, T.; Pope, D.; Lie, R.T.; Díaz, A.; McCracken, J.; Arana, B.; Smith, K.R.; Bruce, N. Eye discomfort, headache and back pain among Mayan Guatemalan women taking part in a randomised stove intervention trial. J. Epidemiol. Community Health 2007, 61, 74–79.
54. Vitoux, M.A.; Kessal, K.; Baudouin, C.; Laprévote, O.; Melik Parsadaniantz, S.; Achard, S.; Brignole-Baudouin, F. Formaldehyde Gas Exposure Increases Inflammation in an In Vitro Model of Dry Eye. Toxicol. Sci. 2018, 165, 108–117.
55. Gupta, S.; Fink, M.K.; Martin, L.M.; Sinha, P.R.; Rodier, J.T.; Sinha, N.R.; Hesemann, N.P.; Chaurasia, S.S.; Mohan, R.R. A rabbit model for evaluating ocular damage from acrolein toxicity in vivo. Ann. N. Y. Acad. Sci. 2020, 1480, 233–245.
56. Li, J.; Zhang, G.; Nian, S.; Lv, Y.; Shao, Y.; Qiao, N.; Liang, R.; Huang, L.; Luo, A. Dry eye induced by exposure to cigarette smoke pollution: An in vivo and in vitro study. Free. Radic. Biol. Med. 2020, 153, 187–201.
57. Lee, K.; Hong, S.; Seong, G.J.; Kim, C.Y. Cigarette Smoke Extract Causes Injury in Primary Retinal Ganglion Cells via Apoptosis and Autophagy. Curr. Eye Res. 2016, 41, 1367–1372.
58. Smith, C.A.; Vianna, J.R.; Chauhan, B.C. Assessing retinal ganglion cell damage. Eye 2017, 31, 209–217.
59. Lee, A.J.; Rochtchina, E.; Wang, J.J.; Healey, P.R.; Mitchell, P. Does smoking affect intraocular pressure? Findings from the Blue Mountains Eye Study. J. Glaucoma 2003, 12, 209–212.
60. Jain, V.; Jain, M.; Abdull, M.M.; Bastawrous, A. The association between cigarette smoking and primary open-angle glaucoma: A systematic review. Int. Ophthalmol. 2017, 37, 291–301.
61. Pérez-de-Arcelus, M.; Toledo, E.; Martínez-González, M.; Martín-Calvo, N.; Fernández-Montero, A.; Moreno-Montañés, J. Smoking and incidence of glaucoma: The SUN Cohort. Medicine 2017, 96, e5761.
62. Tan, G.; Li, J.; Yang, Q.; Wu, A.; Qu, D.Y.; Wang, Y.; Ye, L.; Bao, J.; Shao, Y. Air pollutant particulate matter 2.5 induces dry eye syndrome in mice. Sci. Rep. 2018, 8, 17828.
63. Reports of the Surgeon General. In The Health Consequences of Smoking: A Report of the Surgeon General; Centers for Disease Control and Prevention (US): Atlanta, GA, USA, 2004.
64. Nagata, M.; Kojima, M.; Sasaki, K. Effect of vitamin E eye drops on naphthalene-induced cataract in rats. J. Ocul. Pharmacol. Ther. 1999, 15, 345–350.
65. Jetten, N.; Verbruggen, S.; Gijbels, M.J.; Post, M.J.; De Winther, M.P.; Donners, M.M. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis 2014, 17, 109–118.
66. Ambient (Outdoor) Air Quality and Health. Available online: https://www.who.int/mediacentre/factsheets/fs313/en/ (accessed on 22 September 2021).
67. Min, K.B.; Min, J.Y. Association of Ambient Particulate Matter Exposure with the Incidence of Glaucoma in Childhood. Am. J. Ophthalmol. 2020, 211, 176–182.
68. Xu, G.T.; Zigler, J.S., Jr.; Lou, M.F. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (ALO1576). Exp. Eye Res. 1992, 54, 63–72.
69. Baccarelli, A.; Zanobetti, A.; Martinelli, I.; Grillo, P.; Hou, L.; Giacomini, S.; Bonzini, M.; Lanzani, G.; Mannucci, P.M.; Bertazzi, P.A.; et al. Effects of exposure to air pollution on blood coagulation. J. Thromb. Haemost. 2007, 5, 252–260.
70. Schaumberg, D.A.; Mendes, F.; Balaram, M.; Dana, M.R.; Sparrow, D.; Hu, H. Accumulated lead exposure and risk of age-related cataract in men. JAMA 2004, 292, 2750–2754.
71. Zhong, J.-Y.; Lee, Y.-C.; Hsieh, C.-J.; Tseng, C.-C.; Yiin, L.-M. Association between Dry Eye Disease, Air Pollution and Weather Changes in Taiwan. Int. J. Environ. Res. Public Health 2018, 15, 2269.
72. Bourcier, T.; Viboud, C.; Cohen, J.C.; Thomas, F.; Bury, T.; Cadiot, L.; Mestre, O.; Flahault, A.; Borderie, V.; Laroche, L. Effects of air pollution and climatic conditions on the frequency of ophthalmological emergency examinations. Br. J. Ophthalmol. 2003, 87, 809–811.
73. Lodovici, M.; Bigagli, E. Oxidative stress and air pollution exposure. J. Toxicol. 2011, 2011, 487074.
74. Torricelli, A.; Novaes, P.; Matsuda, M.; Alves, M.; Monteiro, M. Ocular surface adverse effects of ambient levels of air pollution. Arq. Bras. De Oftalmol. 2011, 74, 377–381.
75. Novaes, P.; do Nascimento Saldiva, P.H.; Kara-José, N.; Macchione, M.; Matsuda, M.; Racca, L.; Berra, A. Ambient levels of air pollution induce goblet-cell hyperplasia in human conjunctival epithelium. Environ. Health Perspect. 2007, 115, 1753–1756.
76. Nita, M.; Grzybowski, A. Smoking and Eye Pathologies. A Systemic Review. Part I. Anterior Eye Segment Pathologies. Curr. Pharm. Des. 2017, 23, 629–638.
77. Fullerton, D.G.; Bruce, N.; Gordon, S.B. Indoor air pollution from biomass fuel smoke is a major health concern in the developing world. Trans. R. Soc. Trop. Med. Hyg. 2008, 102, 843–851.
78. Saha, A.; Kulkarni, P.K.; Shah, A.; Patel, M.; Saiyed, H.N. Ocular morbidity and fuel use: An experience from India. Occup. Environ. Med. 2005, 62, 66–69.
79. Pokhrel, A.K.; Smith, K.R.; Khalakdina, A.; Deuja, A.; Bates, M.N. Case-control study of indoor cooking smoke exposure and cataract in Nepal and India. Int. J. Epidemiol. 2005, 34, 702–708.
80. Liu, H.; Begley, C.; Chen, M.; Bradley, A.; Bonanno, J.; McNamara, N.A.; Nelson, J.D.; Simpson, T. A link between tear instability and hyperosmolarity in dry eye. Invest. Ophthalmol. Vis. Sci. 2009, 50, 3671–3679.
81. Bron, A.J.; Abelson, M.B.; Ousler, G.; Pearce, E.; Tomlinson, A.; Yokoi, A.; Smith, J.A.; Begley, C.; Caffery, B.; Nichols, K. Methodologies to diagnose and monitor dry eye disease: Report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf. 2007, 5, 108–152.
82. González, M.M.; Solano, M.M.; Porco, T.C.; Oldenburg, C.E.; Acharya, N.R.; Lin, S.C.; Chan, M.F. Epidemiology of uveitis in a US population-based study. J. Ophthalmic Inflamm. Infect. 2018, 8, 6.
83. Yuen, B.G.; Tham, V.M.; Browne, E.N.; Weinrib, R.; Borkar, D.S.; Parker, J.V.; Uchida, A.; Vinoya, A.C.; Acharya, N.R. Association between Smoking and Uveitis: Results from the Pacific Ocular Inflammation Study. Ophthalmology 2015, 122, 1257–1261.
84. Lin, P.; Loh, A.R.; Margolis, T.P.; Acharya, N.R. Cigarette smoking as a risk factor for uveitis. Ophthalmology 2010, 117, 585–590.
85. Roesel, M.; Ruttig, A.; Schumacher, C.; Heinz, C.; Heiligenhaus, A. Smoking complicates the course of non-infectious uveitis. Graefe’s Arch. Clin. Exp. Ophthalmol. 2011, 249, 903–907.
86. Sarir, H.; Mortaz, E.; Karimi, K.; Kraneveld, A.D.; Rahman, I.; Caldenhoven, E.; Nijkamp, F.P.; Folkerts, G. Cigarette smoke regulates the expression of TLR4 and IL-8 production by human macrophages. J. Inflamm. 2009, 6, 12.
87. Gonçalves, R.B.; Coletta, R.D.; Silvério, K.G.; Benevides, L.; Casati, M.Z.; da Silva, J.S.; Nociti, F.H., Jr. Impact of smoking on inflammation: Overview of molecular mechanisms. Inflamm. Res. 2011, 60, 409–424.
88. Iho, S.; Tanaka, Y.; Takauji, R.; Kobayashi, C.; Muramatsu, I.; Iwasaki, H.; Nakamura, K.; Sasaki, Y.; Nakao, K.; Takahashi, T. Nicotine induces human neutrophils to produce IL-8 through the generation of peroxynitrite and subsequent activation of NF-kappaB. J. Leukoc. Biol. 2003, 74, 942–951.
89. Curnow, S.J.; Falciani, F.; Durrani, O.M.; Cheung, C.M.; Ross, E.J.; Wloka, K.; Rauz, S.; Wallace, G.R.; Salmon, M.; Murray, P.I. Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest. Ophthalmol. Vis. Sci. 2005, 46, 4251–4259.
90. Valentincic, N.V.; de Groot-Mijnes, J.D.; Kraut, A.; Korosec, P.; Hawlina, M.; Rothova, A. Intraocular and serum cytokine profiles in patients with intermediate uveitis. Mol. Vis. 2011, 17, 2003–2010.
91. Khera, T.K.; Copland, D.A.; Boldison, J.; Lait, P.J.; Szymkowski, D.E.; Dick, A.D.; Nicholson, L.B. Tumour necrosis factor-mediated macrophage activation in the target organ is critical for clinical manifestation of uveitis. Clin. Exp. Immunol. 2012, 168, 165–177.
92. Quintana, F.J.; Basso, A.S.; Iglesias, A.H.; Korn, T.; Farez, M.F.; Bettelli, E.; Caccamo, M.; Oukka, M.; Weiner, H.L. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453, 65–71.
93. Yoon, S.; Han, S.; Jeon, K.J.; Kwon, S. Effects of collected road dusts on cell viability, inflammatory response, and oxidative stress in cultured human corneal epithelial cells. Toxicol. Lett. 2018, 284, 152–160.
94. Li, L.; Xing, C.; Zhou, J.; Niu, L.; Luo, B.; Song, M.; Niu, J.; Ruan, Y.; Sun, X.; Lei, Y. Airborne particulate matter (PM2.5) triggers ocular hypertension and glaucoma through pyroptosis. Part. Fibre Toxicol. 2021, 18, 10.
95. Zeng, Y.; Li, M.; Zou, T.; Chen, X.; Li, Q.; Li, Y.; Ge, L.; Chen, S.; Xu, H. The Impact of Particulate Matter (PM2.5) on Human Retinal Development in hESC-Derived Retinal Organoids. Front. Cell Dev. Biol. 2021, 9, 607341.
96. Sun, H.Y.; Luo, C.W.; Chiang, Y.W.; Yeh, K.L.; Li, Y.C.; Ho, Y.C.; Lee, S.S.; Chen, W.Y.; Chen, C.J.; Kuan, Y.H. Association Between PM2.5 Exposure Level and Primary Open-Angle Glaucoma in Taiwanese Adults: A Nested Case-Control Study. Int. J. Environ. Res. Public Health 2021, 18, 1714.
97. Veldhoen, M.; Hirota, K.; Westendorf, A.M.; Buer, J.; Dumoutier, L.; Renauld, J.C.; Stockinger, B. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453, 106–109.
98. Torii, K.; Saito, C.; Furuhashi, T.; Nishioka, A.; Shintani, Y.; Kawashima, K.; Kato, H.; Morita, A. Tobacco smoke is related to Th17 generation with clinical implications for psoriasis patients. Exp. Dermatol. 2011, 20, 371–373.
99. Escobar, T.; Yu, C.R.; Muljo, S.A.; Egwuagu, C.E. STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis. Investig. Ophthalmol. Vis. Sci. 2013, 54, 4017–4025.
100. Wang, R.X.; Yu, C.R.; Mahdi, R.M.; Egwuagu, C.E. Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells. J. Biol. Chem. 2012, 287, 36012–36021.
101. Jadidi-Niaragh, F.; Mirshafiey, A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand. J. Immunol. 2011, 74, 1–13.
102. van Hamburg, J.P.; Asmawidjaja, P.S.; Davelaar, N.; Mus, A.M.; Colin, E.M.; Hazes, J.M.; Dolhain, R.J.; Lubberts, E. Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum. 2011, 63, 73–83.
103. Zhang, L.; Li, J.M.; Liu, X.G.; Ma, D.X.; Hu, N.W.; Li, Y.G.; Li, W.; Hu, Y.; Yu, S.; Qu, X.; et al. Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J. Clin. Immunol. 2011, 31, 606–614.
104. Smith, W.; Assink, J.; Klein, R.; Mitchell, P.; Klaver, C.C.; Klein, B.E.; Hofman, A.; Jensen, S.; Wang, J.J.; de Jong, P.T. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 2001, 108, 697–704.
105. Khan, J.C.; Thurlby, D.A.; Shahid, H.; Clayton, D.G.; Yates, J.R.; Bradley, M.; Moore, A.T.; Bird, A.C. Smoking and age related macular degeneration: The number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br. J. Ophthalmol. 2006, 90, 75–80.
106. Smith, W.; Mitchell, P.; Leeder, S.R. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch. Ophthalmol. 1996, 114, 1518–1523.
107. Bai, Y.C.; Wang, C.Y.; Lin, C.L.; Lai, J.N.; Wei, J.C. Association Between Air Pollution and the Risk of Uveitis: A Nationwide, Population-Based Cohort Study. Front. Immunol. 2021, 12, 613893.
108. Pons, M.; Marin-Castano, M.E. Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: A possible mechanism for CNV in passive smokers with AMD. Invest. Ophthalmol. Vis. Sci. 2011, 52, 3842–3853.
109. Nita, M.; Grzybowski, A. Smoking and Eye Pathologies. A Systemic Review. Part II. Retina Diseases, Uveitis, Optic Neuropathies, Thyroid-Associated Orbitopathy. Curr. Pharm. Des. 2017, 23, 639–654.
110. Govindaraju, V.K.; Bodas, M.; Vij, N. Cigarette smoke induced autophagy-impairment regulates AMD pathogenesis mechanisms in ARPE-19 cells. PLoS ONE 2017, 12, e0182420.
111. Chang, C.J.; Yang, H.H.; Chang, C.A.; Tsai, H.Y. Relationship between air pollution and outpatient visits for nonspecific conjunctivitis. Invest. Ophthalmol. Vis. Sci. 2012, 53, 429–433.